Low blood-brain barrier permeability to azidothymidine (AZT), 3TC, and thymidine in the rat

Brain Res. 1998 Apr 27;791(1-2):313-6. doi: 10.1016/s0006-8993(98)00139-5.


The blood-brain barrier (BBB) permeability to [3H]-azidodeoxythymidine (AZT), deoxythiacytidine (3TC), and thymidine was studied using both an intravenous injection/external organ (IV/EO) method and an internal carotid artery perfusion (ICAP) technique in parallel with [14C]-sucrose as a plasma volume marker. The brain volumes of distribution (VD) of the three compounds approximated that of sucrose with either method. Although the lipid solubility of AZT, as determined by the 1-octanol/buffer partition coefficient (P), was 16-fold higher than that of thymidine, the BBB permeability-surface area (PS) products were almost identical, consistent with preferential efflux of AZT from brain to blood.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-HIV Agents / pharmacokinetics*
  • Blood-Brain Barrier / drug effects*
  • Drug Evaluation, Preclinical
  • Lamivudine / pharmacokinetics*
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Thymidine / pharmacokinetics*
  • Zidovudine / pharmacokinetics*


  • Anti-HIV Agents
  • Lamivudine
  • Zidovudine
  • Thymidine